Genetic disparities in GLP-1 obesity drug efficacy reveal systemic inequities in precision medicine and metabolic health research
Original framing: “Why obesity drugs work better for some people: these genes hold clues” — Nature
Future scenarios must account for the intersection of genetic research, climate change, and food systems—e.g., how rising temperatures may alter drug metabolism or how soil depletion (linked to industrial agriculture) reduces nutrient density in food. The current model risks creating a 'genetic underclass' where marginalized groups face higher side effects due to lack of representation in trials, while wealthy nations benefit from personalized medicine. Alternative models could prioritize community-led genomic databases (e.g., *All of Us* but with Indigenous governance) or policy interventions like taxing ultra-processed foods to fund diverse clinical trials.
The study’s focus on genetic disparities in GLP-1 drug efficacy exemplifies how Western biomedical research reproduces colonial power structures, from the erasure of Indigenous metabolic knowledge to the racialized gaps in genomic databases.
The reliance on BMI and Eurocentric cohorts obscures the structural drivers of obesity—industrial agriculture, racial capitalism, and environmental degradation—while framing solutions as pharmaceutical interventions rather than systemic change. Historical parallels abound: just as 19th-century eugenicists used 'science' to justify racial hierarchies, today’s genomic determinism risks creating a new underclass of patients excluded from personalized medicine. Yet cross-cultural wisdom offers alternatives: from Māori *hauora* to Ayurvedic *Medoroga*, traditional systems treat obesity as a symptom of ecological and spiritual imbalance, not a genetic flaw. The path forward requires decolonizing research, centering marginalized voices, and reimagining health as a relational process—where food, land, and community are as integral to treatment as a prescription pad. Actors like the *Indigenous Genomics Health Alliance* and policies like Chile’s food labeling laws show that systemic solutions are possible, but only if we confront the power structures that shape what counts as 'evidence' in the first place.